Bloomage Biotech(SH:688363) Zheng Quan Zhi Xing·2025-08-29 17:46Core Viewpoint - The controlling shareholder of Huaxi Biotechnology Co., Ltd., Huaxi Xinyu Investment Co., Ltd., has initiated a share buyback plan, expressing confidence in the company's future development and long-term investment value [1] Group 1: Buyback Plan Details - The buyback plan will commence on August 8, 2025, and will last for six months, with a planned investment of no less than RMB 200 million and no more than RMB 300 million [1] - The buyback will not exceed 1% of the company's total share capital, and the purchase price will not exceed RMB 70 per share [1] Group 2: Initial Buyback Execution - On August 27 and 28, 2025, Huaxi Xinyu purchased a total of 1,533,569 shares, representing approximately 0.32% of the company's total share capital, for a total amount of RMB 88,683,021.15 [2][5] - The shares were acquired through the Shanghai Stock Exchange's centralized bidding system [5] Group 3: Shareholder Information - Huaxi Xinyu Investment Co., Ltd. is the controlling shareholder, holding 283,500,000 shares, which accounts for 59.17% of the total share capital [3][5] - The company has identified consistent action among shareholders, including the actual controller and chairman, Zhao Yan, who holds a significant stake through various entities [3][4] Group 4: Future Buyback Plans - The company will continue to execute the buyback plan using self-owned or raised funds, with ongoing monitoring of the buyback progress [5][6]